Pottstown Memorial Regional Cancer Center (PMRCC) offers clinical trials, also called clinical research protocols, for patients with many types of cancer including breast, colon, lung, urinary, prostate, lymphoma and non-Hodgkins lymphoma.

PMRCC participates in clinical trials because we want to help find new ways to help treat cancer and find new combinations of treatment. Clinical trials are used to test new drugs or to discover new approaches to radiation therapy and surgery.

“The goal of cancer research is to discover ways to prevent, diagnose, treat and control cancer now and in future generations,” notes PMRCC Clinical Research Coordinator Dot Freeman, RN, OCN.

“For example, we are participating in an exciting research study of the oral drug Tykerb® which is available to women with advanced breast cancer who meet certain criteria. This new drug access program is another way for women to receive treatment,” notes Ms. Freeman.

In addition to clinical research studies, PMRCC has also participated in prevention studies for breast and prostate cancer. “The studies may play an important role in discovering the answer for cancer prevention,” says Ms. Freeman.

PMRCC has plans this year to offer a breast cancer prevention study for women at high risk for the disease. For more information about participating in clinical research studies, contact Dot Freeman at 610-327-7544.